The effect on bone-mineral density of perindopril as an antihypertensive drug in osteoporosis patients Osteoporozlu hastalarda antihipertansif i̇laç olarak perindoprilin kemik mineral yoǧunluǧuna etkisi
Turkiye Klinikleri Journal of Medical Sciences, cilt.26, sa.4, ss.375-379, 2006 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 26 Sayı: 4
- Basım Tarihi: 2006
- Dergi Adı: Turkiye Klinikleri Journal of Medical Sciences
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.375-379
- Anahtar Kelimeler: Bone density, Osteoporosis, Perindopril, Postmenopausal
- Trakya Üniversitesi Adresli: Evet
Özet
Objective: The purpose of this study was to investigate the effect on bone-mineral density (BMD) of perindopril as an antihypertensive treatment in conjunction with osteoporosis treatment in hypertensive postmenopausal women. Material and Methods: Seventy postmenopausal women treated with alendronate were enrolled in this study. Menopausal women with osteoporosis and mild or moderate hypertension were administered perindopril 4 mg/day, alendronate 70 mg/week and calcium 1000 mg/day (group 1; n= 36 patients). The other group consisted of postmenopausal women without hypertension treated by alendronate 70 mg/week and calcium 1000 mg/day (group 2; n= 34 patients). BMD of patients was evaluated before and after 1 year of treatment. Results: BMD results suggested significant improvements in L2-L4, L2 and L4 scores in both groups after 1 year of treatment. For the L3 score, although there was no difference in group 1, improvement was detected in group 2. In the trochanter region, we did not observe a significant improvement in any group; however, significant improvement was detected in the femur neck only in group 2. There was no significant difference in BMD values between the two groups after treatment (p> 0.05). Conclusion: In conclusion, according to the results of 1-year treatment, the use of perindopril for concurrent hypertension in patients using alendronate for postmenopausal osteoporosis does not have a clear negative effect on BMD values. Copyright © 2006 by Türkiye Klinikleri.